FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,150,968 | -10.0% | 259,227 | -33.1% | 0.00% | – |
| Q2 2023 | $1,279,516 | +50.8% | 387,732 | +30.2% | 0.00% | – |
| Q1 2023 | $848,762 | -63.0% | 297,811 | -5.6% | 0.00% | -100.0% |
| Q4 2022 | $2,296,316 | -17.7% | 315,428 | -8.5% | 0.00% | 0.0% |
| Q3 2022 | $2,789,000 | +100.2% | 344,730 | +21.3% | 0.00% | – |
| Q2 2022 | $1,393,000 | -75.2% | 284,305 | +19.6% | 0.00% | -100.0% |
| Q1 2022 | $5,621,000 | +274.2% | 237,642 | +180.0% | 0.00% | – |
| Q4 2021 | $1,502,000 | -14.8% | 84,883 | +35.8% | 0.00% | – |
| Q3 2021 | $1,763,000 | +512.2% | 62,502 | +127.6% | 0.00% | – |
| Q2 2021 | $288,000 | +70.4% | 27,466 | +91.2% | 0.00% | – |
| Q1 2021 | $169,000 | -2.9% | 14,367 | -3.3% | 0.00% | – |
| Q4 2020 | $174,000 | -5.9% | 14,857 | -46.7% | 0.00% | – |
| Q3 2019 | $185,000 | – | 27,871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |